Evidence map›Paper›PMID 40256779›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Inhibition of energy metabolism in macrophages to block MPS for enhancing the chemotherapy efficacy.

Li Bin, Linlin Huang, Aiyu Chen, Yinyi Yang, Yanmei Zheng, Hanwen Zhang, Qinfang Zhang, Jiahui Zheng, Meiting Qiu, Xiajin Li and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Li BinDepartment of Medical College, Guangxi University of Science and Technology, Liuzhou, China.
Linlin HuangDepartment of Medical College, Guangxi University of Science and Technology, Liuzhou, China.
Aiyu ChenDepartment of Medical College, Guangxi University of Science and Technology, Liuzhou, China.
Yinyi YangDepartment of Medical College, Guangxi University of Science and Technology, Liuzhou, China.
Yanmei ZhengDepartment of Medical College, Guangxi University of Science and Technology, Liuzhou, China.
Hanwen ZhangDepartment of Medical College, Guangxi University of Science and Technology, Liuzhou, China.
Qinfang ZhangDepartment of Medical College, Guangxi University of Science and Technology, Liuzhou, China.
Jiahui ZhengDepartment of Medical College, Guangxi University of Science and Technology, Liuzhou, China.
Meiting QiuDepartment of Medical College, Guangxi University of Science and Technology, Liuzhou, China.
Xiajin LiDepartment of Medical College, Guangxi University of Science and Technology, Liuzhou, China.
Yangbo TanDepartment of Medical College, Guangxi University of Science and Technology, Liuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various biological barriers hinder the effective use of administered nanoparticles, with the mononuclear phagocyte system (MPS) being a major obstacle to their

Indexed as

chemotherapyenergy metabolismglucose transporter 1metastasisMPS

Identifiers

PMID40256779
PMCPMC12006136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.